Arriving in the arena of weight management management, retatrutide represents a unique strategy. Unlike many existing medications, retatrutide works as a twin agonist, simultaneously engaging both GLP-like peptide-1 (GLP-1) and glucose-dependent insulinotropic substance (GIP) receptors. The simultaneous activation promotes various advantageous effe